Log in to save to my catalogue

Evaluation of Plecanatide for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel S...

Evaluation of Plecanatide for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel S...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2423799298

Evaluation of Plecanatide for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation in Patients 65 Years or Older

About this item

Full title

Evaluation of Plecanatide for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation in Patients 65 Years or Older

Publisher

United States: Elsevier Inc

Journal title

Clinical therapeutics, 2020-07, Vol.42 (7), p.1406-1414.e4

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

AbstractPurposeChronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) are common functional gastrointestinal disorders. The prevalence of constipation-related issues tends to increase with age. This analysis pooled data from Phase III trials in CIC and IBS-C to assess the safety and efficacy of plecanatide in p...

Alternative Titles

Full title

Evaluation of Plecanatide for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation in Patients 65 Years or Older

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2423799298

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2423799298

Other Identifiers

ISSN

0149-2918

E-ISSN

1879-114X

DOI

10.1016/j.clinthera.2020.05.012

How to access this item